Loss of A-to-I editing stimulates SARS-CoV-2 anti-viral responses
A-to-I 编辑缺失会刺激 SARS-CoV-2 抗病毒反应
基本信息
- 批准号:10353022
- 负责人:
- 金额:$ 25.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAddressAlu ElementsAntiviral ResponseBloodCOVID-19Cell LineCell LineageCellsDangerousnessDendritic CellsDiseaseDouble-Stranded RNAElementsEpithelial CellsEquilibriumGene ExpressionGenerationsGenesGenetic TranscriptionGenomicsHumanHuman GenomeIL8 geneImmune responseInfectionInflammation MediatorsInflammatoryInflammatory ResponseInterferonsInterleukin-1Interleukin-6InterruptionKineticsLeadLungMeasuresMediatingNF-kappa BNaturePathogenicityPatientsPattern recognition receptorPlayRNARNA EditingRNA chemical synthesisRoleSARS-CoV-2 antiviralSARS-CoV-2 infectionSignal TransductionSmall Interfering RNAStructureTLR3 geneTNF geneTestingViralVirus DiseasesVirus Replicationbronchial epitheliumchemokinecomputational pipelinescytokinedsRNA adenosine deaminasehelicaseknock-downparticlepreventprogramsresponsesensorsevere COVID-19tissue culturetranscriptome sequencingviral RNA
项目摘要
Host pattern recognition receptors TLR3, and the DExD/H-box helicases, RIG-I and MDA5 sense viral RNA
and activate IRF and NF-kB transcription factors culminating in generation of host anti-viral responses. Infection
of dendritic cells (DC) or mf with SARS-CoV-2 results in an abortive infection without viral replication. In contrast,
infection of normal human bronchial epithelial cells (NHBE) with SARS-CoV-2 results in robust viral replication.
Infection of both cell lineages with SARS-CoV-2 generates similar robust host anti-viral responses as measured
by induction of type 1 interferons (IFN1), interferon-stimulated genes (ISGs), TNF-a, IL-1, IL-6, IL-8, other
cytokines, chemokines and other pro-inflammatory mediators.
Alu elements make up ~10% of the human genome. Alu RNAs are abundant in human cells and, because
of their repetitive nature, can form double-stranded RNAs (dsRNA) and stimulate above-cited pattern recognition
receptors and a strong anti-viral response in the absence of viral infection. To prevent this, Alu RNAs are rapidly
A-to-I edited by adenosine deaminase specific for dsRNA, ADAR. Our preliminary studies show that severe
COVID-19 disease (COV-S) is associated with marked loss of A-to-I editing of endogenous Alu RNAs in both
blood and lung, while mild COVID-19 disease (COV-M) is associated with a partial loss of A-to-I editing. Infection
of DC as well as NHBE causes a marked loss of A-to-I editing of endogenous Alu RNAs. Our preliminary studies
show that unedited Alu RNAs activate host dsRNA sensors and stimulate transcriptional response leading to
induction of ISGs, IL-6, and IL-8. In contrast, the same Alu RNAs, if edited, as is seen in healthy controls or
mock-infected cells, fail to activate these gene expression programs.
Taken together, these results suggest the following hypothesis we propose to address. First, unedited Alu
RNAs are continuously synthesized and exist at high levels in cells. If unedited, Alu RNAs form dsRNAs that
stimulate potentially pathogenic anti-viral responses. However, Alu RNAs are continuously A-to-I edited so they
cannot form dsRNAs. In response to viral infection, this continuous cycle is rapidly disrupted by loss of A-to-I
editing by ADAR allowing accumulation of unedited Alu dsRNAs and stimulation of downstream anti-viral host
responses. It is tempting to speculate that the value to the host of this unique continuous cycle is to rapidly
stimulate anti-viral and pro-inflammatory host responses by Alu dsRNAs in response to viral infection to prevent
accumulation and spread of pathogenic viral particles.
To explore this hypothesis, we propose to infect mf, DC, and NHBE with SARS-CoV-2 and follow kinetics of
loss of A-to-I editing of endogenous Alu RNAs and host responses using RNA-seq and our computational
pipelines. We will also determine if RNAs that stimulate host responses are of viral origin or are Alu dsRNAs.
In aim II, we will investigate ability of unedited and edited Alu RNAs to stimulate anti-viral responses and employ
siRNA-mediated knockdown of Alu RNAs to demonstrate a direct role of Alu RNAs in the host anti-viral response.
宿主模式识别受体TLR 3和DExD/H-box解旋酶、RIG-I和MDA 5正义病毒RNA
并激活IRF和NF-κ B转录因子,最终产生宿主抗病毒应答。感染
树突状细胞(DC)或mf与SARS-CoV-2的结果是流产感染没有病毒复制。与此相反的是,
用SARS-CoV-2感染正常人支气管上皮细胞(NHBE)导致病毒的稳健复制。
用SARS-CoV-2感染两种细胞系产生了类似的强有力的宿主抗病毒应答,
通过诱导1型干扰素(IFN 1)、干扰素刺激基因(ISG)、TNF-α、IL-1、IL-6、IL-8、其他
细胞因子、趋化因子和其它促炎介质。
Alu元件占人类基因组的约10%。Alu RNA在人类细胞中很丰富,
它们的重复性质,可以形成双链RNA(dsRNA)并刺激上述模式识别
受体和强的抗病毒反应,在没有病毒感染。为了防止这种情况,Alu RNA迅速
由对dsRNA特异的腺苷脱氨酶,阿达尔编辑的A至I。我们的初步研究表明,
COVID-19疾病(COV-S)与内源性Alu RNA的A-to-I编辑的显著丢失相关,
血液和肺,而轻度COVID-19疾病(COV-M)与A-to-I编辑的部分丧失有关。感染
DC以及NHBE的释放导致内源性Alu RNA的A至I编辑的显著损失。我们的初步研究
显示未编辑Alu RNA激活宿主dsRNA传感器并刺激转录应答,导致
诱导ISG、IL-6和IL-8。相比之下,相同的Alu RNA,如果被编辑,如在健康对照或
模拟感染的细胞,不能激活这些基因表达程序。
综上所述,这些结果表明了我们提出的以下假设。首先,未编辑的Alu
RNA持续合成,并在细胞中以高水平存在。如果未经编辑,Alu RNA形成dsRNA,
刺激潜在致病性抗病毒反应。然而,Alu RNA是连续的A到I编辑,因此它们
不能形成dsRNA。在病毒感染时,这种连续的循环被A到I的丢失迅速破坏。
通过阿达尔编辑,允许未编辑的Alu dsRNA的积累和下游抗病毒宿主的刺激
应答人们很容易推测,这种独特的连续循环对宿主的价值是迅速地
通过Alu dsRNA响应病毒感染刺激抗病毒和促炎宿主应答,
病原性病毒颗粒的积累和传播。
为了探索这一假设,我们建议用SARS-CoV-2感染mf、DC和NHBE,并跟踪其动力学。
使用RNA-seq和我们的计算方法,
管道我们还将确定刺激宿主反应的RNA是病毒来源的还是Alu dsRNA。
在目的II中,我们将研究未编辑和编辑的Alu RNA刺激抗病毒应答的能力,并采用
siRNA介导的Alu RNA敲低,以证明Alu RNA在宿主抗病毒应答中的直接作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas M. Aune其他文献
Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44.
OKT3 引起的人类 T 细胞激活可被 CD44 单克隆抗体抑制。
- DOI:
10.4049/jimmunol.147.8.2493 - 发表时间:
1991 - 期刊:
- 影响因子:4.4
- 作者:
B. Rothman;M. Blue;Kevin Kelley;D. Wunderlich;D. Mierz;Thomas M. Aune - 通讯作者:
Thomas M. Aune
Methotrexate and its mechanisms of action in inflammatory arthritis
甲氨蝶呤及其在炎性关节炎中的作用机制
- DOI:
10.1038/s41584-020-0373-9 - 发表时间:
2020-02-17 - 期刊:
- 影响因子:32.700
- 作者:
Bruce N. Cronstein;Thomas M. Aune - 通讯作者:
Thomas M. Aune
Bromodomain inhibitor JQ1 reversibly blocks IFN-γ production
溴结构域抑制剂 JQ1 可逆性地阻断 IFN-γ 的产生
- DOI:
10.1038/s41598-019-46516-x - 发表时间:
2019-07-16 - 期刊:
- 影响因子:3.900
- 作者:
Hunter R. Gibbons;Deborah J. Mi;Virginia M. Farley;Tashawna Esmond;Mary B. Kaood;Thomas M. Aune - 通讯作者:
Thomas M. Aune
Thomas M. Aune的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas M. Aune', 18)}}的其他基金
Alu dsRNAs as adjuvants for influenza vaccines
Alu dsRNA 作为流感疫苗佐剂
- 批准号:
10605272 - 财政年份:2022
- 资助金额:
$ 25.95万 - 项目类别:
Alu dsRNAs as adjuvants for influenza vaccines
Alu dsRNA 作为流感疫苗佐剂
- 批准号:
10453106 - 财政年份:2022
- 资助金额:
$ 25.95万 - 项目类别:
Loss of A-to-I editing stimulates SARS-CoV-2 anti-viral responses
A-to-I 编辑缺失会刺激 SARS-CoV-2 抗病毒反应
- 批准号:
10615086 - 财政年份:2022
- 资助金额:
$ 25.95万 - 项目类别:
LncRNAs tether transcription factors to enable locus-specific regulation and sustain memory T cell phenotype
LncRNA 束缚转录因子以实现位点特异性调节并维持记忆 T 细胞表型
- 批准号:
9387202 - 财政年份:2017
- 资助金额:
$ 25.95万 - 项目类别:
Long non-coding RNA signatures to distinguish fibromyalgia syndrome from rheumatic diseases
长非编码 RNA 特征可区分纤维肌痛综合征和风湿性疾病
- 批准号:
9555179 - 财政年份:2017
- 资助金额:
$ 25.95万 - 项目类别:
Long non-coding RNA signatures to classify multiple sclerosis
用于对多发性硬化症进行分类的长非编码 RNA 特征
- 批准号:
9405679 - 财政年份:2016
- 资助金额:
$ 25.95万 - 项目类别:
Long non-coding RNA signatures to classify multiple sclerosis
用于对多发性硬化症进行分类的长非编码 RNA 特征
- 批准号:
9136402 - 财政年份:2016
- 资助金额:
$ 25.95万 - 项目类别:
Cell cycle checkpoint defects lead to chronic inflammation in RA
细胞周期检查点缺陷导致 RA 慢性炎症
- 批准号:
8683107 - 财政年份:2013
- 资助金额:
$ 25.95万 - 项目类别:
Cell cycle checkpoint defects lead to chronic inflammation in RA
细胞周期检查点缺陷导致 RA 慢性炎症
- 批准号:
8582351 - 财政年份:2013
- 资助金额:
$ 25.95万 - 项目类别:
Control of Thymocyte Development and Rag Expression by Zfp608
Zfp608 对胸腺细胞发育和 Rag 表达的控制
- 批准号:
7895604 - 财政年份:2009
- 资助金额:
$ 25.95万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 25.95万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 25.95万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 25.95万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 25.95万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 25.95万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 25.95万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 25.95万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 25.95万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 25.95万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 25.95万 - 项目类别:
Research Grant














{{item.name}}会员




